Inmed PharmaceuticalsINM
13F holders, Q3 2025 (September 30)9holders +2
5new positions
3sold out
1famous investor
$2.19avg. 13F price*
At the end of Q3 2025, 9 institutions reported holding Inmed Pharmaceuticals Inc. (INM) in their 13F filings, up 2 from Q2 2025. 5 opened new positions and 3 sold out. The largest holders were Sabby Management, LLC ($482K), DRW Securities, LLC ($79K) and Virtu Financial LLC ($45K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Inmed Pharmaceuticals Inc.
- CUSIP
- 457637700
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $665K |
| Exits | 3 | $27K |
All 13F filers, Q2 2025 → Q3 2025: 303,282 shares bought and 8,163 shares sold, net +295,119 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Sabby Management, LLC | 2.52% | New | 219,998 | $482K |
| DRW Securities, LLC | 0.00% | New | 35,865 | $79K |
| Virtu Financial LLC | 0.00% | New | 20,369 | $45K |
| Renaissance Technologies | 0.00% | New | 16,800 | $37K |
| Thompson Davis & Co., Inc. | 0.01% | New | 10,249 | $22K |
| SBI Securities Co., Ltd. | 0.00% | No change | 300 | $657 |
| Federation des caisses Desjardins du Quebec | 0.00% | Add +100.0% | 2 | $4 |
| AllSquare Wealth Management LLC | 0.00% | No change | 1 | $2 |
| Banque Cantonale Vaudoise | 0.00% | No change | 6 | $0 |
"% of holder's portfolio" is INM's weight in each manager's 13F, not the share of Inmed Pharmaceuticals Inc. the manager owns.